Clinical Trial Update: Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cisplatin plus raltitrexed or cisplatin plus 5-fluorouracil with radiotherapy for head and neck squamous cell carcinoma; current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Adrucil (5-fluorouracil)
• CISPLATIN (cisplatin)
• Tomudex (ZD1694)

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Head and Neck Squamous Cell Cancer | Phase 3 | Status: UNKNOWN